USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
US Autoimmune Disease Diagnostics Market, Forecast to 2020
US Autoimmune Disease Diagnostics Market, Forecast to 2020
Systemic Autoimmune Diseases to Spur Double-digit Market Growth as Participants Look to Unmet Needs and Game-changing Strategies to Boost Revenues
24-Feb-2016
North America
Description
According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as well as localized diseases, such as celiac, IBD, IBS, and Hashimoto's. Systemic diseases dominate the market due to their high prevalence in the United States and also because of the market participation of large diagnostics companies, such as Inova Diagnostics, Siemens Healthcare, Abbott Diagnostics, and Beckman Coulter. The localized disease segment is the fastest-growing, mainly due to celiac, as gluten intolerance in the United States is increasing at an exponential rate.
Table of Contents
Scope and Segmentation
Key Predictions: US Autoimmune Disease Diagnostics Market
Current Trends in the Autoimmune Disease Diagnostics Market
Autoimmune Disease Diagnostics Market—Overview
Key Companies to Watch
Ecosystem of the Autoimmune Disease Diagnostics Market
Significance of the Autoimmune Disease Diagnostics Market
Significance of the Autoimmune Disease Diagnostics Market—Prevalence Rates
Competitive Landscape
Key Diseases and Available Solutions in the US Market
Key Diseases and Available Solutions in the US Market (continued)
LDTs—Role in Autoimmune Disease Diagnostics
Segment Lifecycle Analysis by Disease
Overall Market Forecast
Overall Disease Segment Share
Competitive SWOT Analysis by Company
Competitive SWOT Analysis by Company (continued)
Where do the Opportunities Lie in this Market?
Pharma and Diagnostics Business Integration
Autoimmune Diagnostics Companies are Uniting with Pharmaceuticals to Diversify Revenue Channels
Direct-to-Consumer Market: The Risk and The Opportunity
Localized Disease Diagnostics Segment Revenue
Growth Rate by Localized Autoimmune Diseases
Competitive Value Matrix—Localized Disease Diagnostics Segment
Autoimmune Tests—Role in Patient Continuum
Systemic Disease Diagnostics Segment Revenue
Growth Rate by Systemic Autoimmune Diseases
Competitive Value Matrix—Systemic Disease Diagnostics Segment
Autoimmune Tests—Role in Patient Continuum
Key Conclusions and Future Outlook
Legal Disclaimer
Celiac Disease-specific LDT Assays
Chron’s Disease-specific LDT Assays
RA-specific LDT Assays
Lupus-specific LDT Assays
IBD/IBS-specific LDT Assays
Others
Learn More—Next Steps
List of Exhibits
List of Exhibits (continued)
List of Exhibits (continued)
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Popular Topics
| No Index | No |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | 9AB9-00-48-00-00 |
| Keyword 1 | Autoimmune Disease Diagnostics |
| Keyword 2 | US Autoimmune Disease Diagnostics |
| Keyword 3 | Disease Diagnostics |
| Is Prebook | No |